Press Enter or click the Search button above to view results.

Recent Drug Updates

  • daratumumab (Darzalex) FDA approved daratumumab in combination with pomalidomide and dexamethasone for patients with multiple myeloma
  • c1 inhibitor human (Haegarda) FDA approved first subcutaneous c1 inhibitor to prevent hereditary angioedema attacks in adolescents and adults
  • dabrafenib (Tafinlar) FDA approved dabrafenib in combination with trametinib for metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation
  • trametinib (Mekinist) FDA approved dabrafenib in combination with trametinib for metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation
  • betrixaban (Bevyxxa) FDA approves FXa inhibitor for VTE prophylaxis caused by restricted mobility
  • abobotulinumtoxinA (Dysport) Indication for spasticity in adults expanded to include both upper and lower limbs